Extraordinary Dividends and Form B Registrations After an Insurance Company Acquisition

The acquisition of an insurance company does not end the regulatory relationship with state insurance commissioners. It creates a new one. From the day of closing, the acquirer and every entity in the insurance holding company system are subject to the NAIC Model Holding Company Act as adopted in the insurer's state of domicile, which governs the annual registration of the holding company, the approval of material intercompany transactions, the payment of dividends, and the reporting of enterprise-level risks. These obligations are not discretionary and they do not depend on the size of the insurer or the sophistication of the acquirer. They are statutory requirements that attach to the holding company structure as a matter of law.

For strategic acquirers, the post-closing compliance calendar is an operational matter to be assigned to the regulatory affairs function and monitored by outside insurance counsel. For sponsor acquirers, the holding company regime raises additional questions that go directly to transaction economics: how much cash can be extracted from the insurance subsidiary, on what timeline, through what mechanism, and subject to what regulatory constraints. The extraordinary dividend formula, the intercompany agreement approval process, and the risk-based capital framework collectively determine the answer to those questions, and they must be analyzed at the transaction structuring stage rather than after the acquisition closes.

This sub-article is part of the Insurance Company M&A: Form A Filings, State Approvals, and Closing an Insurance Holding Company Deal guide. It covers post-closing holding company obligations in detail: the statutory dividend formula and state variants, notice and approval requirements for extraordinary dividends, Form B annual registration, Form C and Form D intercompany agreement filings, tax-sharing and service agreement requirements, Form F enterprise risk reporting, ORSA timing and content, capital extraction planning for sponsor acquirers, upstream guarantees and regulatory restrictions, structural change notifications, and ongoing compliance governance.

Acquisition Stars advises acquirers and sponsors on insurance holding company compliance, intercompany agreement structuring, dividend planning, and regulatory relationships with state insurance departments. Nothing in this article constitutes legal advice for any specific transaction.

Post-Closing Holding Company Obligations at a Glance

The NAIC Model Holding Company Act, which has been adopted in substantially similar form by most states, imposes a comprehensive regulatory framework on every entity that is part of an insurance holding company system. The system includes the insurer itself, the ultimate controlling entity, and every intermediate holding company, subsidiary, or affiliate that is under common control with the insurer. The Act's requirements attach automatically at closing and apply to the combined structure from that point forward regardless of how recently the acquisition was completed or whether the new owners were previously familiar with the insurance regulatory framework.

The core post-closing obligations fall into five categories. First, annual registration: each insurer that is a member of a holding company system must file a Form B registration statement with its domiciliary commissioner on an annual basis, describing the structure and members of the holding company system, identifying controlling persons, and disclosing material transactions and relationships. Second, transaction approval: material intercompany transactions, including dividends above the ordinary course threshold, intercompany loans, service agreements, reinsurance arrangements, and asset transfers, require prior notice to or approval by the commissioner before they may be executed. Third, agreement filings: specific categories of intercompany agreements, including management agreements, service agreements, cost allocation arrangements, and tax-sharing agreements, must be filed with the commissioner on Form C or Form D depending on the state. Fourth, enterprise risk reporting: the ultimate controlling entity must file an annual Form F enterprise risk report with the lead state commissioner. Fifth, ORSA: insurers and groups above applicable premium thresholds must conduct and document an annual Own Risk and Solvency Assessment and submit a summary report to the commissioner.

These obligations do not replace the insurer's separate ongoing obligations under state insurance codes, including financial statement filings, risk-based capital reports, market conduct compliance, and licensing maintenance. They layer on top of those obligations and require dedicated compliance infrastructure to manage reliably. Acquirers who do not have prior experience in regulated insurance entities consistently underestimate the staffing and outside counsel resources required to maintain the holding company compliance calendar.

The Extraordinary Dividend Formula and State Variants

The ordinary dividend threshold, below which an insurer may pay dividends without prior commissioner approval or advance notice, is defined by statute in the insurer's state of domicile. The NAIC Model Holding Company Act defines an ordinary dividend as any dividend or distribution that, together with all other dividends and distributions made within the preceding 12 months, does not exceed the greater of 10% of the insurer's surplus as regards policyholders as of the end of the prior calendar year, or the insurer's net gain from operations (for life and health insurers) or net income (for property and casualty insurers) for the prior calendar year. Any dividend or distribution that exceeds this threshold is by definition an extraordinary dividend subject to prior notice or approval.

The state variants matter significantly in practice. Several states, including New York and California, use the lesser-of formulation rather than the greater-of formulation in the NAIC model. Under the lesser-of standard, the ordinary dividend threshold is the smaller of the 10% surplus figure and the prior-year net income figure. When surplus is large relative to net income, which is common for established insurers with long operating histories, the lesser-of standard dramatically reduces the amount that can be paid without extraordinary dividend review. Other states impose additional conditions on ordinary dividends, such as requiring that the dividend be paid from earned surplus rather than paid-in capital, or requiring that the insurer's financial condition following payment meet minimum surplus thresholds independent of the formula.

A minority of states require prior commissioner approval for any dividend above the ordinary threshold, not merely prior notice. In approval states, the insurer cannot pay the extraordinary dividend until the commissioner affirmatively approves it, which introduces timing uncertainty that depends on the commissioner's processing capacity and any information requests the department issues in connection with its review. In notice states, the insurer may pay the dividend if the commissioner has not disapproved it within 30 days of the notice. Acquirers modeling post-closing cash flows should map each insurer in the portfolio to its domiciliary state's formula and the applicable notice or approval requirement before finalizing dividend projections.

Notice vs. Approval Requirements

The procedural distinction between a notice requirement and an approval requirement is consequential for timing and certainty. Under a notice requirement, the insurer provides written notice to the commissioner of its intention to pay the extraordinary dividend at least 30 days before the proposed payment date, along with documentation supporting the insurer's calculation of the extraordinary amount. The commissioner reviews the notice and may disapprove the dividend or impose conditions. If the commissioner takes no action within the 30-day notice period, the dividend is deemed approved and may be paid on the specified date. The notice regime creates a predictable timeline: the insurer bears the risk of disapproval during the window, but if no objection is received, payment can proceed without waiting for affirmative action.

Under an approval requirement, the insurer must obtain the commissioner's written approval before the dividend may be paid. The 30-day period is a minimum review window, not a deemed-approval period. Commissioners in approval states may request additional information, extend the review period, condition approval on specific undertakings by the insurer or the holding company, or deny approval altogether. In practice, experienced commissioners in approval states develop a track record that allows counsel to estimate the likely processing time for a straightforward extraordinary dividend with adequate documentation, but no statutory deadline compels the commissioner to act within any fixed period.

The notice or approval submission should include, at minimum: a calculation of the ordinary dividend threshold showing the 10% surplus figure and the prior-year net income or net gain figure, with the applicable state formula applied; the insurer's most recent statutory financial statements; a description of the insurer's current RBC ratio and minimum surplus position; an explanation of the business purpose for the dividend; and a representation that payment of the dividend will not impair the insurer's ability to meet its policyholder obligations or maintain minimum required surplus. Departments that receive well-documented extraordinary dividend submissions move through review more efficiently than those that receive bare notice with minimal supporting documentation.

Form B Annual Holding Company Registration

The Form B annual holding company registration statement is the central disclosure document of the insurance holding company compliance regime. Every insurer that is a member of a holding company system must file Form B with its domiciliary commissioner annually. The filing deadline varies by state but most commonly falls within 90 days after the close of the insurer's fiscal year, producing a March 31 annual deadline for calendar-year insurers. Some states impose a June 1 deadline; a small number align the deadline with the filing of the insurer's annual financial statement. Acquirers should confirm the applicable deadline in each insurer's domiciliary state immediately after closing.

The content requirements for Form B are comprehensive. The registration must identify every member of the holding company system, including entities that are not themselves insurers, and describe the ownership relationships among them with sufficient specificity to allow the commissioner to understand the chain of control from the insurer to the ultimate controlling party. It must include biographical affidavits for all directors and senior officers of the ultimate controlling entity, covering prior business experience, pending regulatory proceedings, and any criminal history. It must describe the financial condition of each member of the holding company system based on the most recently available financial statements. It must disclose all material transactions between members of the holding company system during the prior year, including intercompany dividends, loans, service transactions, and asset transfers that exceed the state's material transaction threshold.

The Form B must be amended promptly if any of the disclosed information changes materially during the year. Material changes include changes in ownership or control of any member of the holding company system, the addition or removal of members from the system through acquisition or divestiture, changes in the identity of directors or senior officers of the ultimate controlling entity, and the commencement of material litigation or regulatory proceedings at any member of the system. The requirement to amend the registration on an ongoing basis means that the compliance function must monitor holding company developments throughout the year, not only during the annual filing cycle.

Form C and Form D Intercompany Agreements

The NAIC Model Holding Company Act requires that certain categories of intercompany agreements be filed with the domiciliary commissioner on a prescribed form before they become effective. The form designations used across states vary, but the two primary filing categories follow the NAIC model's Form C structure for agreements requiring prior notice or approval, and Form D for transactions that require prior approval due to their size or nature relative to the insurer's financial position. The practical effect is that intercompany agreements in the specified categories cannot be implemented until the filing has been made and either approved by the commissioner or allowed to pass without objection through the applicable notice period.

Categories of agreements typically subject to filing include: management agreements between the insurer and an affiliate; service and cost-sharing agreements; lease agreements for property used by the insurer; reinsurance agreements with affiliates; guarantees or surety bonds provided by the insurer for the benefit of an affiliate; and any agreement that materially affects the insurer's financial condition or operations. In many states, any agreement between the insurer and an affiliate in which the aggregate annual payment by the insurer exceeds a threshold, typically 0.5% of the insurer's admitted assets or 3% of surplus, constitutes a material transaction requiring prior filing. Agreements below those thresholds may still require notification on a quarterly or annual basis as part of the Form B disclosure.

Post-closing, the first priority for new acquirers is to inventory all existing intercompany agreements and confirm which ones have been filed and approved. Agreements that were not filed when originally entered into are subject to retroactive scrutiny during examination. If the examination team discovers unfiled agreements, the commissioner may require immediate filing, rescind the agreement, or impose sanctions. New acquirers who inherit unfiled agreements should proactively disclose and file them with the department rather than wait for examination discovery, which typically results in more favorable treatment. The filing backlog should be resolved within the first year of ownership to avoid it becoming a pattern of non-compliance.

Tax-Sharing, Service, and Cost Allocation Agreements

Three specific categories of intercompany agreements are particularly significant for post-closing holding company management: tax-sharing agreements, management and service agreements, and cost allocation arrangements. Each presents distinct regulatory requirements and practical structuring considerations. Tax-sharing agreements govern how the consolidated federal income tax liability of the holding company group is allocated among its members, including the insurer. State insurance regulators scrutinize these agreements closely because they govern whether cash tax payments flow from the insurer to the parent, whether tax refunds attributable to the insurer's losses or credits are returned to the insurer, and whether the arrangement unfairly extracts value from the regulated entity.

The regulatory standard for tax-sharing agreements is that the insurer must be treated no worse than it would be on a separate-return basis. An agreement that allocates more tax liability to the insurer than its standalone obligation, or that allows the parent to retain tax benefits generated by the insurer's losses without compensating the insurer, is subject to commissioner objection and may be rescinded. Sponsors who intend to implement consolidated tax filing arrangements post-closing should engage insurance regulatory counsel before finalizing the agreement structure to confirm that the allocation methodology will be defensible under the applicable state standard.

Management and service agreements must price the services provided to the insurer at arm's-length rates. The most common structure allocates costs on an actual cost basis for services that can be directly attributed to the insurer, and uses a reasonable allocation methodology (such as headcount, revenue, or asset-based allocation) for shared overhead costs. The agreement must specify the services covered, the pricing methodology, the billing and payment terms, and the conditions under which the insurer may terminate the agreement. Commissioners routinely request documentation supporting the arm's-length pricing during examination, and agreements that lack supporting benchmarking analysis are more likely to generate examination findings.

Form F Enterprise Risk Report

The Form F enterprise risk report is an annual filing required from the person or entity that is the ultimate controlling party of an insurance holding company system. The filing obligation rests at the top of the holding company structure, not at the insurer level, which means that for sponsor-owned insurers the filing obligation falls on the fund or its general partner as the ultimate controlling entity. The Form F is confidential and is submitted to the lead state commissioner, which is the commissioner of the domiciliary state of the largest insurer in the holding company system by premium volume. The lead state commissioner shares the Form F with other state regulators through the supervisory college framework established under the NAIC model.

The Form F covers enterprise-level risks that could have a material adverse effect on the financial condition of the insurer or the holding company system as a whole. Required disclosure categories include: the capital adequacy and liquidity position of the ultimate controlling entity and each intermediate holding company, with emphasis on any debt service obligations that could drain liquidity from the holding company system; the nature and scope of any intra-group reinsurance, guarantee, or credit support arrangements; significant investment concentrations or correlated risk exposures at the portfolio level; material off-balance-sheet arrangements, contingent liabilities, or pending litigation at the holding company level that could affect the insurer's financial condition; and any events or developments since the prior Form F filing that materially changed the enterprise risk profile.

For sponsor acquirers, the Form F disclosure of capital adequacy and liquidity at the ultimate controlling entity level can be sensitive. Commissioners who review the Form F may ask follow-up questions about the fund's debt service capacity, the timing of any planned recapitalizations or dividend recaps, and whether the fund's investment timeline creates pressure for capital extraction from the insurer that could impair its financial condition. The Form F is not a public document, but it should be prepared with the recognition that it will be reviewed by regulators who have authority to restrict dividends and require additional capital contributions to the insurer if they conclude the enterprise risk profile poses a material risk to policyholders.

ORSA Summary Report Timing and Content

The Own Risk and Solvency Assessment requirement applies to insurers and insurance groups that exceed applicable premium thresholds. For individual insurers, the NAIC model threshold is annual gross written premiums of at least $500 million. For insurance groups, the threshold is annual gross written premiums of at least $1 billion across all members. Commissioners retain discretion to require an ORSA from insurers below these thresholds if the insurer's risk profile or financial condition justifies additional scrutiny, but mandatory ORSA filings are concentrated among larger institutions. Below-threshold insurers should nonetheless be aware of ORSA requirements because growth, acquisition activity, or commissioner discretion can cause the obligation to arise.

The ORSA is an internal process: the insurer or insurance group must conduct and document an ongoing assessment of the risks inherent in its business plan and its capital adequacy relative to those risks, using its own risk management framework and internal models. The ORSA summary report submitted to the commissioner is a summary of that internal process and its key outputs; it is not a standardized form but must meet content requirements set out in the NAIC ORSA Guidance Manual. The summary report typically covers the description of the insurer's or group's risk management framework; the identification and assessment of material risks across underwriting, credit, market, liquidity, and operational risk categories; the results of the capital adequacy assessment under base and stress scenarios; and the relationship between the ORSA results and the insurer's strategic and business planning processes.

The ORSA summary report is filed with the lead state commissioner on an annual basis, with a deadline typically set by the insurer's domiciliary state. The report is confidential. Because the ORSA is an internal risk management exercise with an external reporting component, insurers that are newly acquired need to assess whether the existing ORSA process and documentation meet the standard expected by regulators under the new holding company structure, particularly if the acquisition changes the insurer's risk profile materially by adding new lines of business, new geographic exposures, or new reinsurance arrangements.

Capital Extraction Planning for Sponsor Acquirers

Sponsor acquirers of insurance companies face a structural challenge that distinguishes insurance M&A from most other regulated industry acquisitions: the primary asset, the insurer's balance sheet, is subject to regulatory oversight of its dividend and capital management decisions in a way that most corporate assets are not. The extraordinary dividend framework, the risk-based capital requirements, and the commissioner's broad discretionary authority to restrict dividends that impair financial condition collectively determine the rate at which capital can be extracted from the insurer and returned to the fund's investors.

Capital extraction planning should begin during due diligence with a multi-year model that projects available ordinary dividends, extraordinary dividend capacity, and the insurer's expected RBC ratio under different dividend scenarios. The model should apply the correct state formula, account for the 12-month rolling aggregation of all distributions when testing against the ordinary threshold, and test the impact of planned dividends on the insurer's surplus and RBC ratio. Scenarios that would reduce the insurer's RBC ratio below the Company Action Level (typically 200% of authorized control level) warrant particular scrutiny, because commissioner attention intensifies at that threshold and dividend restrictions are more likely to be imposed.

Alternative capital extraction mechanisms beyond ordinary dividends include intercompany loans from the insurer to the parent, asset sales from the insurer to affiliates at fair value, and surplus note issuances. Each of these mechanisms is subject to regulatory filing and approval requirements as material intercompany transactions. Intercompany loans must bear market-rate interest and have defined repayment terms. Asset transfers must be at fair market value. Surplus notes are subordinated instruments that require commissioner approval and are subject to specific restrictions on repayment. Sponsors who intend to use these mechanisms should evaluate the regulatory approval process and timeline for each before incorporating them into the capital extraction plan.

Upstream Guarantees, Liens, and Regulatory Restrictions

Insurance regulators impose significant restrictions on the ability of the insurer to provide credit support for holding company obligations. An insurer that guarantees the debt obligations of its parent, pledges its assets as collateral for holding company borrowings, or enters into any arrangement that exposes its assets to claims from the holding company's creditors is providing value that effectively subordinates policyholder claims to holding company debt. This outcome is inconsistent with the regulatory mission of ensuring the insurer maintains adequate resources to pay its policyholders, and insurance codes in most states prohibit or restrict such arrangements.

The practical consequence is that acquisition financing structures that rely on assets of the acquired insurer as collateral for deal debt are generally impermissible. Private equity sponsors who are accustomed to using portfolio company assets to support acquisition financing must structure insurance holding company acquisitions with the insurer's assets ring-fenced from holding company debt. The acquisition debt sits at the holding company level or above and is serviced from dividends flowing up from the insurer, not from direct claims on the insurer's assets. This constraint materially affects the achievable leverage in an insurance company acquisition and the debt service coverage the acquisition structure can support, because dividend capacity is limited by the extraordinary dividend framework and by the RBC floor.

Intercompany guarantees that run in the other direction, from the holding company to the insurer, are generally permissible and may be required by regulators as a condition of approving the acquisition or an extraordinary dividend request. A parent guarantee of the insurer's obligations provides comfort to regulators that the holding company will support the insurer's financial condition if unexpected losses arise, and it may allow the insurer to maintain a lower level of internal surplus than it would otherwise need. Such guarantees are disclosed on the Form B and the Form F, and may need to be filed as intercompany transactions if they meet applicable materiality thresholds.

Change of Structure Notifications and Re-Filings

Any change in the structure of the insurance holding company system after the initial Form A approval may require notice to or approval from the domiciliary commissioner. Structural changes include the reorganization of intermediate holding companies, the transfer of ownership interests in the insurer among entities within the existing holding company system, the addition of new members to the holding company system through acquisition, the removal of members through divestiture, and any change in the ultimate controlling entity or the chain of control from the insurer to the ultimate controlling party. The thresholds that trigger notification or approval requirements vary by state and by the nature of the change, but the general principle is that any transaction that alters the structure of the holding company system or changes the identity of controlling persons requires regulatory attention.

Internal restructurings that are common in private equity-owned holding companies, such as the merger of intermediate holding companies to simplify the corporate structure, the conversion of holding companies to different entity types, or the formation of new intermediate entities to facilitate financing arrangements, each require evaluation under the holding company statute to determine whether a Form A pre-approval filing or a notice filing is required. Some states have a simplified approval process for internal reorganizations that do not change the ultimate controlling party and do not affect the insurer's financial condition, but most states require at minimum a notice filing describing the structural change before it is implemented.

Secondary market sales of equity interests in the holding company that constitute a change of control at the ultimate controlling entity level require full Form A pre-approval in the insurer's state of domicile, just as the original acquisition did. A fund-to-fund transfer or a sale of the insurance holding company to a new sponsor therefore triggers the same regulatory review and approval process as the original acquisition, with all of the associated timing and risk considerations. Sponsors should factor the Form A approval timeline into any exit planning and engage insurance regulatory counsel well in advance of a planned sale process to ensure the new acquirer understands the regulatory approval requirements.

Ongoing Compliance Calendar and Governance

The holding company compliance calendar for an insurance acquisition is dense and recurs annually with few exceptions. The core annual cycle includes the Form B registration statement, the Form F enterprise risk report, the ORSA summary report (for qualifying insurers), the insurer's annual statutory financial statement and risk-based capital report, and the filing of any required amendments to the Form B for material changes during the year. These filings have staggered deadlines that create a nearly continuous filing cycle for compliance functions managing multiple insurers in multiple domiciliary states.

Governance structures for holding company compliance should include a designated regulatory compliance officer with insurance regulatory expertise, outside insurance regulatory counsel retained to manage filing preparation and commissioner relationships, a compliance calendar maintained and monitored at the holding company level that tracks all state-specific deadlines, and a board-level oversight process that receives regular reports on compliance status and any open regulatory matters. For sponsor-owned insurers, the compliance governance structure must bridge the institutional knowledge gap between the fund's general investment professionals and the specialized insurance regulatory expertise required to manage holding company obligations effectively.

Regulatory examinations by domiciliary departments occur on a periodic basis, typically every three to five years, and cover the insurer's financial condition, market conduct, and holding company compliance, including the completeness and accuracy of Form B filings, the approval status of intercompany agreements, and the propriety of intercompany transactions. Acquirers who inherit a holding company with compliance gaps should proactively remediate them before the next examination cycle, because deficiencies discovered during examination are more difficult to resolve without regulatory sanction than deficiencies self-reported to the department in advance. A well-run compliance function that maintains current filings and proactive communication with the department is a material factor in sustaining a constructive regulatory relationship that supports the holding company's operating and capital management objectives.

Frequently Asked Questions